Cephalosporin-3′-diazeniumdiolates: Targeted NO-Donor Prodrugs for Dispersing Bacterial Biofilms

被引:125
作者
Barraud, Nicolas [2 ,3 ]
Kardak, Bharat G. [1 ]
Yepuri, Nageshwar R. [1 ]
Howlin, Robert P. [5 ,6 ,7 ]
Webb, Jeremy S. [5 ,6 ,7 ]
Faust, Saul N. [5 ,6 ,8 ,9 ]
Kjelleberg, Staffan [2 ,3 ,4 ]
Rice, Scott A. [2 ,3 ,4 ]
Kelso, Michael J. [1 ]
机构
[1] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia
[2] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia
[3] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia
[4] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore
[5] Univ Southampton, NIHR Resp Biomed Res Unit, Southampton SO9 5NH, Hants, England
[6] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[7] Univ Southampton, Ctr Biol Sci, Southampton SO9 5NH, Hants, England
[8] Univ Southampton, NIHR Wellcome Trust Clin Res Facil, Southampton SO9 5NH, Hants, England
[9] Southampton Univ Hosp, NHS Fdn Trust, Southampton, Hants, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
antibiotics; biofilms; cephalosporins; nitric oxide; prodrugs; NITRIC-OXIDE DONORS; PSEUDOMONAS-AERUGINOSA; AGENTS; INFECTIONS; HYDROLYSIS;
D O I
10.1002/anie.201202414
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Just say NO to biofilms: NO-donors are used to disperse a bacterial biofilm so that co-administered antibiotics will kill the more susceptible unattached cells. The chemically stable cephalosporin-3'-diazeniumdiolate NO-donor prodrug (see scheme) is activated by bacterial β-lactamases and facilitates this two-step biofilm erradication. Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:9057 / 9060
页数:4
相关论文
共 26 条
  • [1] Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa
    Barraud, Nicolas
    Hassett, Daniel J.
    Hwang, Sung-Hei
    Rice, Scott A.
    Kjelleberg, Staffan
    Webb, Jeremy S.
    [J]. JOURNAL OF BACTERIOLOGY, 2006, 188 (21) : 7344 - 7353
  • [2] Nitric Oxide Signaling in Pseudomonas aeruginosa Biofilms Mediates Phosphodiesterase Activity, Decreased Cyclic Di-GMP Levels, and Enhanced Dispersal
    Barraud, Nicolas
    Schleheck, David
    Klebensberger, Janosch
    Webb, Jeremy S.
    Hassett, Daniel J.
    Rice, Scott A.
    Kjelleberg, Staffan
    [J]. JOURNAL OF BACTERIOLOGY, 2009, 191 (23) : 7333 - 7342
  • [3] Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms
    Barraud, Nicolas
    Storey, Michael V.
    Moore, Zoe P.
    Webb, Jeremy S.
    Rice, Scott A.
    Kjelleberg, Staffan
    [J]. MICROBIAL BIOTECHNOLOGY, 2009, 2 (03) : 370 - 378
  • [4] Understanding biofilm resistance to antibacterial agents
    Davies, D
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (02) : 114 - 122
  • [5] Anaerobic Metabolism Occurs in the Substratum of Gonococcal Biofilms and May Be Sustained in Part by Nitric Oxide
    Falsetta, Megan L.
    McEwan, Alastair G.
    Jennings, Michael P.
    Apicella, Michael A.
    [J]. INFECTION AND IMMUNITY, 2010, 78 (05) : 2320 - 2328
  • [6] Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles
    Hetrick, Evan M.
    Shin, Jae Ho
    Paul, Heather S.
    Schoenfisch, Mark H.
    [J]. BIOMATERIALS, 2009, 30 (14) : 2782 - 2789
  • [7] Antibiotic resistance of bacterial biofilms
    Hoiby, Niels
    Bjarnsholt, Thomas
    Givskov, Michael
    Molin, Soren
    Ciofu, Oana
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (04) : 322 - 332
  • [8] Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates
    Keefer, LK
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 : 585 - 607
  • [9] Nitric Oxide Regulation of Cyclic di-GMP Synthesis and Hydrolysis in Shewanella woodyi
    Liu, Niu
    Xu, Yueming
    Hossain, Sajjad
    Huang, Nick
    Coursolle, Dan
    Gralnick, Jeffrey A.
    Boon, Elizabeth M.
    [J]. BIOCHEMISTRY, 2012, 51 (10) : 2087 - 2099
  • [10] New antibiotic agents and approaches to treat biofilm-associated infections
    Lynch, Anthony S.
    Abbanat, Darren
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (10) : 1373 - 1387